CONSORT Statement

The official reporting guideline working to improve the transparency of clinical trial reporting since 1996! Tweets by @LarissaShamseer

[CONSORT Statement @CONSORTing]

Doug Altman, a driver behind CONSORT & founding director of the @EQUATORNetwork, passed away on 3 June 2018. He leaves behind an incredible legacy to medical research & stats. Doug, thank you for sharing your brilliance, inspiration & kindness with us all. https://t.co/gEXxRNpua6

[Gary Collins @GSCollins]

NEW Commentary in @NatureMedicine on why/how the SPIRIT & CONSORT reporting guidelines for #clinicaltrials are being updated

-> https://t.co/fxEMWCMH9Z

Sign up here to have your say on what should be included

-> https://t.co/kkUV5WX2m0

#statstwitter #medtwitter #transparency

[CONSORT Statement @CONSORTing]

Calling all patients, carers, healthcare professionals, and researchers working on or using #clinicaltrials! Help shape the next update of the CONSORT and SPIRIT reporting guidelines! Sign up here to have your say on what should be included: https://t.co/Qqe64W9bQR

[CONSORT Statement @CONSORTing]

Calling all patients, carers, healthcare professionals, and researchers working on or using #clinicaltrials! Help shape the next update of the CONSORT and SPIRIT reporting guidelines! Sign up here to have your say on what should be included: https://t.co/Qqe64W9bQR

[EQUATOR Network @EQUATORNetwork]

Have you tried the new @CONSORTing extension for multi-arm parallel-group #clinicaltrials? Let us know what you think of it! https://t.co/rqdyWGdQ2K

[Restoring Invisible & Abandoned Trials @RIATinitiative]

The 2019 RIAT grant competition launches today! Two awards of $150K (US) are available to help you restore a misreported or unpublished trial. More details on our website: https://t.co/AeA85GCcq6

[CONSORT Statement @CONSORTing]

Lovely tribute to #Cochrane #CONSORT #PRISMA contributor, Doug Altman

[Carl Moons @CarlMoons]

Cochrane Editorial - Doug Altman's legacy to Cochrane and evidence synthesis | Cochrane Library https://t.co/wYnFoUSboj

Tribute to Doug Altman’s legacy to Cochrane and the medical scientific world in general. Let his work and eloquent manners remain an example to us all.

[CONSORT Statement @CONSORTing]

@avi33t Also see #CONSORT extension on N-of-1 trials more information/resource on biomedical N-of-1 trials: https://t.co/lXeWqjgfzy

[CONSORT Statement @CONSORTing]

*** NEW CONSORT extension for better reporting of trials assessing the effects of health equity #consortequity published in @bmj_latest https://t.co/KIZ1s3K4Wg ***

[Cochrane Equity @CochraneEquity]

ICYMI:CONSORT-Equity extension for better reporting of health equity in RCTs https://t.co/MIDnCb8JVd

[U15 Canada @U15ca]

New paper by @OttawaHospital researchers in @NatureHumBehav on actions stakeholders can take to address #predatoryjournals https://t.co/G7t2FDJs1E How stakeholders can respond to the rise of predatory journals

[Munya Dimairo @mdimairo]

@JoyceBrowne @charlesweijer @CONSORTing Here are many reporting guidance under development. We are also developing one on adaptive designs found here too https://t.co/SlQC84uPS6

[Duncan Nicholas @dnjournals]

StatReviewer learns context of paper, establishes expectation: eg. if randomised trial, applies CONSORT guidelines, and apply relevant algorithms
@netricate #houle #ismte2017

[CONSORT Statement @CONSORTing]

John Ioannidis explains the term meta-research, means "after" research #OHResDay

[Brian Nosek (@[email protected]) @BrianNosek]

85% of RCTs didn't adhere to preregistered outcomes. In basic scince, we have no idea bc preregistration is uncommon https://t.co/X93DPhOdSt

[Peer Review Congress #PRC11 Coming 2029! @peerrevcongress]

#PRC8 LiveStream: Editorial and Peer Review Process Innovations. Tweet your questions @peerrevcongress! https://t.co/JAtKfJixbA

[CONSORT Statement @CONSORTing]

@pmmbossuyt describes side effects of STARD for DTA studies - useful as teaching tool, improved terminology, increased registration #PRC8

[Alice Meadows 🇺🇦 @alicejmeadows]

Registered trials are 4.5 times more likely to be published than non-registered says An-Wen Chan #PRC8